Diseases, Conditions, Syndromes

Pfizer launches mRNA flu vaccine trial

US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful COVID-19 shot.

Vaccination

China approves first mixed-vaccine trial as Delta spreads

China's drug regulator has approved the country's first mixed-vaccine trial, a company involved in the study said, as the rapid spread of the Delta variant raises concern about the efficacy of domestically produced jabs.

page 9 from 38